Logo.png
BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway
07 févr. 2022 09h00 HE | BioRestorative Therapies, Inc
BioRestorative Provides Update on its Active Phase 2 Clinical Trial MELVILLE, N.Y., Feb. 07, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:...
scyllalogo2000px.png
Cloud Database Demand Spurs 198% Growth for ScyllaDB
25 janv. 2022 07h45 HE | Scylla DB, Inc.
PALO ALTO, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- ScyllaDB, the database for data-intensive apps that require high performance and low latency, today announced that the company achieved 106%...
BES_Mark.jpg
GCP APPLIED TECHNOLOGIES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of its Investigation of the Sale of GCP and Encourages Investors to Contact the Firm
24 janv. 2022 21h00 HE | Bragar Eagel & Squire
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors of its investigation into whether the officers or...
BES_Mark.jpg
GCP APPLIED TECHNOLOGIES ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of its Investigation of the Sale of GCP and Encourages Investors to Contact the Firm
11 déc. 2021 05h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 11, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors of its investigation into whether the officers or...
BES_Mark.jpg
GCP APPLIED TECHNOLOGIES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of GCP and Encourages Investors to Contact the Firm
06 déc. 2021 13h00 HE | Bragar Eagel & Squire
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...
22157.jpg
Two Day Online Validation, Verification and Transfer of Analytical Methods Seminar: Understanding and implementing Guidelines from FDA/EMA, USP and ICH - October 14-15, 2021
25 août 2021 09h03 HE | Research and Markets
Dublin, Aug. 25, 2021 (GLOBE NEWSWIRE) -- The "Validation, Verification and Transfer of Analytical Methods (Understanding and implementing guidelines from FDA/EMA, USP and ICH) 21" training has been...
Comprehensive Overview of FDA Regulatory Compliance for Drug and Biotech Products: Two Day Virtual Seminar Online (July 27-28, 2021) - Worldcomplianceseminars.com
30 juin 2021 10h00 HE | WCS Consulting Inc.
RALEIGH, N.C., June 30, 2021 (GLOBE NEWSWIRE) -- The “Comprehensive Overview of FDA Regulatory Compliance for Drug and Biotech Products” seminar has been added to worldcomplianceseminars.com...
lightbend-full-color-large.png
Lightbend Launches Akka Serverless, a New Class of Cloud Native Development Platform-as-a-Service
10 juin 2021 08h00 HE | Lightbend, Inc.
SAN FRANCISCO, June 10, 2021 (GLOBE NEWSWIRE) -- Lightbend, the company providing cloud-native microservice frameworks for some of the world’s largest brands, today announced the launch of Akka...
dSyOoKgA.png
A Cloud Guru Introduces New Capabilities For Accelerating and Scaling Enterprise Cloud Deployments
29 avr. 2021 09h00 HE | A Cloud Guru
AUSTIN, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- A Cloud Guru (ACG), the leader in modern tech skills development, today announced the launch of two new product features specifically for businesses...
dSyOoKgA.png
A Cloud Guru Launches New Product Features to Accelerate Cloud Careers
22 avr. 2021 09h00 HE | A Cloud Guru
AUSTIN, Texas, April 22, 2021 (GLOBE NEWSWIRE) -- A Cloud Guru (ACG), the leader in modern tech skills development, today announced the launch of a series of new product features that make it even...